Diagnostic Products. 6.2.1 With respect to Diagnostic Antibody Products, Dyax shall pay to CAT the following payments upon achievement by Dyax or a Dyax Sublicensee (or its sublicensee) of the milestones set out below. For the avoidance of doubt the milestone payments shall be payable in respect of the first Diagnostic Antibody Product to achieve the relevant milestone: First filing for Marketing Authorisation in one Major Market country US $ Marketing Authorisation granted in each Major Market Country US $
Appears in 2 contracts
Samples: Collaboration Agreement (Merrimack Pharmaceuticals Inc), Collaboration Agreement (Merrimack Pharmaceuticals Inc)
Diagnostic Products. 6.2.1 With respect to Diagnostic Antibody Products, Dyax shall pay to CAT the following payments upon achievement by Dyax or a Dyax Sublicensee (or its sublicensee) of the milestones set out below. For the avoidance of doubt the milestone payments shall be payable in respect of the first Diagnostic Antibody Product to achieve the relevant milestone: First filing for Marketing Authorisation in one Major Market country US $ $_____________ Marketing Authorisation granted in each Major Market Country US $_____________
Appears in 1 contract
Samples: Second Technology Transfer and License Agreement (Dyax Corp)
Diagnostic Products. 6.2.1 With respect to Diagnostic Antibody Products, Dyax shall pay to CAT the following payments upon achievement by Dyax or a Dyax Sublicensee (or its sublicensee) of the milestones set out below. For the avoidance of doubt the milestone payments shall be payable in respect of the first Diagnostic Antibody Product to achieve the relevant milestone: First filing for Marketing Authorisation in one Major Market country US $ $[******] Marketing Authorisation granted in each Major Market Country US $[******]
Appears in 1 contract
Samples: Licence Agreement (Dyax Corp)
Diagnostic Products. 6.2.1 With respect to Diagnostic Antibody Products, Dyax shall pay to CAT the following payments upon achievement by Dyax or a Dyax Sublicensee (or its sublicensee) of the milestones set out below. For the avoidance of doubt the milestone payments shall be payable in respect of the first Diagnostic Antibody Product to achieve the relevant milestone: First filing for Marketing Authorisation in one Major Market country US $ $[*****] Marketing Authorisation granted in each Major Market Country US $[*****]
Appears in 1 contract
Samples: Agreement (Dyax Corp)
Diagnostic Products. 6.2.1 With respect to Diagnostic Antibody Products, Dyax shall pay to CAT the following payments upon achievement by Dyax or a Dyax Sublicensee (or its sublicensee) of the milestones set out below. For the avoidance of doubt the milestone payments shall be payable in respect of the first Diagnostic Antibody Product to achieve the relevant milestone: First filing for Marketing Authorisation in one Major Market country US $ $______________ Marketing Authorisation granted in each Major Market Country US $______________
Appears in 1 contract
